The effect of selective serotonin reuptake inhibitors in healthy subjects. A systematic review. (Q37678438)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20088752%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

review article

1 reference

title

The effect of selective serotonin reuptake inhibitors in healthy subjects. A systematic review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20088752%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20088752%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Lars Vedel Kessing

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20088752%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Ulla Knorr

series ordinal

1

1 reference

21 August 2017

publication date

1 May 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20088752%20AND%20SRC:MED&resulttype=core&format=json

Nordic Journal of Psychiatry

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20088752%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20088752%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20088752%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

153-163

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20088752%20AND%20SRC:MED&resulttype=core&format=json

Limitations of diagnostic criteria and assessment instruments for mental disorders. Implications for research and policy

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Selective Alteration of Personality and Social Behavior by Serotonergic Intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Cognitive function in unaffected twins discordant for affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Quality of life in unaffected twins discordant for affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Antidepressants and their effect on sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

REM sleep effects as a biomarker for the effects of antidepressants in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Serotonin and human cognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Facial expression perception: an objective outcome measure for treatment studies in mood disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Antidepressant Drugs and Psychomotor Performance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Antidepressants and sleep: a qualitative review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

The effects of citalopram and fluoxetine on sexual behavior in healthy men: evidence of delayed ejaculation and unaffected sexual desire. A randomized, placebo-controlled, double-blind, double-dummy, parallel group study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Effects of a selective serotonin reuptake inhibitor, fluoxetine, on counterregulatory responses to hypoglycemia in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Effects of 5 weeks of administration of fluoxetine and dothiepin in normal volunteers on sleep, daytime sedation, psychomotor performance and mood.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Effect of fluoxetine, pemoline and placebo on heart period and QT variability in normal humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Paroxetine-induced modulation of cortical activity supporting language representations of action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Effects of desipramine and escitalopram on postprandial symptoms induced by the nutrient drink test in healthy volunteers: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Enhancement of stress-induced pituitary hormone release and cardiovascular activation by antidepressant treatment in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

A comparative study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Serotonergic involvement in the psychosocial dimension of personality

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Modulation of the critical flicker fusion effects of serotonin reuptake inhibitors by concomitant pupillary changes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Verbal memory performance during subchronic challenge with a selective serotonergic and a mixed action antidepressant

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Selective serotonin reuptake inhibitors: Their effect on high-intensity exercise performance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Antidepressant drug treatment modifies the neural processing of nonconscious threat cues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Differential effects of amitriptyline, nefazodone and paroxetine on performance and brain indices of visual selective attention and working memory

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Early effects of paroxetine on serotonin storage, plasma levels, and urinary excretion: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

A comparative study of the interactions of alcohol with amitriptyline, fluoxetine and placebo in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Effects of sertraline on autonomic and cognitive functions in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Fluvoxamine modulates pain sensation and affective processing of pain in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Neuroendocrine, polysomnographic and psychometric observations in healthy subjects at high familial risk for affective disorders: the current state of the 'Munich vulnerability study'.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Assessing subjective sleep reports in the first-degree relatives of antidepressant-treated depressed outpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Therapeutic drug monitoring of psychotropic drugs. TDM "nouveau".

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram v

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08039480903511381

10.3109/08039480903511381

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20088752%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference